Comparative Benchmarking
In the context of the broader market, OKYO competes directly with industry leaders such as MCRB and CSBR. With a market capitalization of $87.12M, it holds a leading position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against MCRB's 100.00% and CSBR's 46.65%. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.
